| 最新丙型病毒性肝炎诊治指南推荐方案 |
| |
| 引用本文： | 张轶俊,张继明. 最新丙型病毒性肝炎诊治指南推荐方案[J]. 世界临床药物, 2012, 0(3): 146-149 |
| |
| 作者姓名： | 张轶俊 张继明 |
| |
| 作者单位： | 复旦大学附属华山医院感染科 |
| |
| 摘 要： | 本文重点围绕2011年欧洲肝病研究学会(EASL)发布的HCV感染的诊疗指南(EASL 2011),以及美国肝病研究学会(AASLD)发布的针对基因1型慢性丙型肝炎病毒感染治疗指南(AASLD 2011),对急、慢性丙型肝炎、难治性丙型肝炎及合并其他并发症的丙型肝炎推荐治疗意见,针对基因1型HCV感染的聚乙二醇化干扰素、利巴韦林和蛋白酶抑制剂三联治疗方案等进行综合分析,以期指导国内临床丙型肝炎的诊治。
|
| 关 键 词： | 丙型肝炎 蛋白酶抑制剂 聚乙二醇化干扰素 利巴韦林 |
Treatment recommended in new guidelines for hepatitis C |
| |
| ZHANG Yi-jun,ZHANG Ji-ming. Treatment recommended in new guidelines for hepatitis C[J]. WORLD CLINICAL DRUGS, 2012, 0(3): 146-149 |
| |
| Authors: | ZHANG Yi-jun ZHANG Ji-ming |
| |
| Affiliation: | (Department of Infectious Diseases,Huashan Hospital,Fudan University,Shanghai,200040,China) |
| |
| Abstract: | This review describes the guideline(EASL 2011) published by European Association for the Study of the Liver(EASL) and the guideline(AASLD 2011) for HCV genotype 1 published by American Association for the Study of Liver Diseases(AASLD)in 2011,offered proposals on the treatment of acute and chronic hepatitis C,refractory hepatitis C and patients with other complications.And also discusses the triple therapy with pegylated interferon,ribavirin and protease inhibitors,which might be helpful for clinical practice. |
| |
| Keywords: | hepatitis C proteinase inhibitor pegylated interferon ribavirin |
| 本文献已被 CNKI 等数据库收录！ |
|
